Patients with pulsatile tinnitus are beset by a sound that surges with every beat of their heart. For those who seek medical ...

Dysregulation of bile acid homoeostasis is a central pathogenic mechanism underlying several liver diseases. A promising therapeutic target for such diseases is the farnesoid X receptor (FXR), a ...

Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company and pioneer in venous sinus stenosis treatment, today announced the Company received U.S. Food and Drug Administration (FDA) ...

Metabolic dysfunction-associated steatohepatitis (MASH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) are progressive chronic liver diseases linked to abnormal bile-acid ...

GE HealthCare's Allia upgrade pathways let providers modernize legacy imaging systems with AI-enabled workflows while ...

GE HealthCare today announced Allia™ platform upgrade pathways designed to help customers modernize select legacy Innova™ and ...

Pharma - The expanding field of peptide-based inquiry has increasingly gravitated toward compounds that interact with ...

Global pivotal Phase 3 trial will evaluate efficacy and safety of atebimetinib + modified gemcitabine/nab-paclitaxel (mGnP) compared to standard ...

Researchers at the Ohio University Heritage College of Osteopathic Medicine have discovered new information about how type 2 diabetes develops and how future treatments may help protect ...

Cingulate Inc ( (CING)) has shared an update. On June 16, 2026, Cingulate Inc. announced that the U.S. Patent and Trademark Office had issued the company its first U.S. patent fully owned on lead ADHD ...

UC Berkeley researchers have identified a specific brain circuit in mice that controls how growth hormone floods the body ...